Gary PiazzaDr. Piazza received his Ph.D. from The University of Alabama at Birmingham in 1986 and pursued postdoctoral studies at the Fox Chase Cancer Center and later at Brown University. Dr. Piazza also gained research experience in the pharmaceutical industr with the Proctor and Gamble Company and later with Cell Pathways Inc. Dr. Piazza returned to academic research in 2001 as the Director of Pharmacology at the Institute for Drug Development in San Antonio and later as a Principal Scientist at Southern Research in Birmingham where he established an independent research program funded by the NCI. In 2011, Dr. Piazza joined the University of South Alabama Mitchell Cancer Institute to hold the appointments of Professor of Oncologic Sciences and Pharmacology; Leader, Chemoprevention and Experimental Therapeutics; and Chief of the Drug Discovery Research Center up until 2021. Currently Dr. Piazza serves as the Head of the Department of Drug Discovery and Development and as Director of the Cancer Research Center in the Harrison School of Pharmacy at Auburn University. His research interests are in the field of cancer drug discovery. His research team has discovered and developed several promising drug candidates including a novel class of pan-RAS inhibitors with high potency and selectivity for cancer cells harboring mutant RAS. Dr. Piazza has been continuously funded by the NIH since 2004 and is a co-founder of ADT Pharmaceuticals LLC in Alabama. Read More Read Less